Aptinyx to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference
EVANSTON, Ill., Dec. 05, 2018 (GLOBE NEWSWIRE) — Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the […]